HYPERTENSION IS ASSOCIATED WITH WORSENED ONCOLOGICAL SURVIVAL OUTCOMES IN PATIENTS UNDERGOING NEPHRECTOMY FOR RENAL CELL CARCINOMA: ANALYSIS OF THE INMARC REGISTRY.

MLA

Saitta, Cesare, et al. “Hypertension Is Associated with Worsened Oncological Survival Outcomes in Patients Undergoing Nephrectomy for Renal Cell Carcinoma: Analysis of the Inmarc Registry.” Urologic Oncology, vol. 42, Mar. 2024, p. S40. EBSCOhost, https://doi.org/10.1016/j.urolonc.2024.01.131.

APA

Saitta, C., Afari, J. A., Hakimi, K., Wang, L., Cortes, J., Meagher, M. F., Liu, F., Mahmood, M., Matian, J., Mansour, M., Nguyen, M. V., Puri, D., Cerrato, C., Yuen, K. L., Derweesh, I. H., Patil, D., Master, V., Tanaka, H., Kobayashi, M., & Fukuda, S. (2024). Hypertension Is Associated with Worsened Oncological Survival Outcomes in Patients Undergoing Nephrectomy for Renal Cell Carcinoma: Analysis of the Inmarc Registry. Urologic Oncology, 42, S40. https://doi.org/10.1016/j.urolonc.2024.01.131

Chicago

Saitta, Cesare, Jonathan A. Afari, Kevin Hakimi, Luke Wang, Julian Cortes, Margaret F. Meagher, Franklin Liu, et al. 2024. “Hypertension Is Associated with Worsened Oncological Survival Outcomes in Patients Undergoing Nephrectomy for Renal Cell Carcinoma: Analysis of the Inmarc Registry.” Urologic Oncology 42 (March): S40. doi:10.1016/j.urolonc.2024.01.131.